TScan Therapeutics has gone through a significant strategic transformation. The company increased its clinical focus, streamlined its pipeline, and advanced toward key clinical milestones, but the website still reflected an earlier stage of its journey.
As a clinical-stage biotechnology company that develops engineered T cell receptor (TCR) therapies for cancer, TScan needed a digital presence that could communicate both scientific and real-world patient impact. While the science was compelling, the story lacked a cohesive structure that connected the company’s platform, pipeline, and progress in a way that investors, physicians, and patients could quickly understand.
The existing website didn’t showcase the complete momentum the company had built. Scientific differentiation, clinical advancement, and long-term vision were represented, but the narrative was difficult to absorb. For investors evaluating the opportunity, physicians looking to understand the science, and patients seeking hope, the experience lacked clarity and an emotional connection.
With important clinical milestones ahead and a need to communicate its direction, TScan needed to redesign its website to better reflect the company it is today and where it is headed.
The existing website no longer reflected TScan Therapeutics’ clinical progress, growing pipeline, or maturity as a public biotechnology company. The challenge was to make its complex science easier to understand while strengthening the connection between its platform, clinical programs, and patient impact.
The new site organizes the story around science, pipeline, company progress, and patients, with clear pathways for different audiences. Design elements inspired by TScan Therapeutics’ existing brand, custom imagery, motion, and a company timeline help communicate both innovation and momentum.
The result is a website that balances scientific credibility with human impact and makes TScan Therapeutics’ story easier for investors, physicians, patients, and partners to understand.
The new public biotech company website includes:
The redesigned website gives the Boston-based, growing public biotech a platform to communicate its scientific leadership, clinical progress, and long-term vision, evolving alongside the company.
